MUSCAT: Ministry of Health began clinical trials involving transfusions of blood plasma from coronavirus survivors into patients who have severe symptoms in a bid to treat the illness, the institutions involved said on Tuesday.
In a statement issued, MOH said it succeeded in conducting the procedure of convalescent plasma extraction and transfusion from people who have recovered from Covid-19.
Plasma, the fluid in blood teeming with antibodies post-illness, has already proven effective in studies to treat infectious diseases including SARS and Ebola.
Read More
- Oman marks World Health Day, highlights commitment to health innovation and digital transformation
- Muscat oncology conference showcases latest advances in immunotherapy and targeted therapy
- Oman health authorities urge people to break fast if serious symptoms appear
- 31% of adults in Oman are clinically obese, Royal Hospital urges healthy lifestyles on World Obesity Day
- Moringa shows promise against cancer cells, Oman study says
The process was done in cooperation between the Central Blood Bank and the Royal Hospital, after many recovered patients cooperated to donate blood plasma in accordance with the controls and standards of international blood banks.
The Ministry stated that the technical screening procedures were carried out in the laboratories of the Central Bank of Blood of the Ministry of Health to extract the immune plasma and then injected it into critical coronavirus cases in the Royal Hospital.
